Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1.50	-243.08	239.49
Graham Fair Price	22.28	1.11	0.90
PEG	2.26	-0.94	-0.96
Price/Book	-10.90	3.16	3.55
Price/Cash Flow	-81.46	82.68	446.08
Prices/Earnings	41.13	-47.75	-81.11
Price/Sales	-51.43	7.21	14.85
Price/FCF	-81.46	82.68	446.08
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-65.77	0.09	0.27
Operating Margin	856.45	-0.05	< 0.005
ROA	-46.27	< 0.005	< 0.005
ROE	-0.01	-0.02	-51.34
ROIC	-0.02	-0.01	47.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.06	-74.32
Dividends QOQ	1.80	-0.62	-65.83
EBIT QOQ	1.14	-17.94	1468.82
EPS QOQ	-0.84	-0.51	39.76
FCF QOQ	-0.84	3.64	335.76
Revenue QOQ	-0.62	0.77	25.10
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	250.65	118.79	-52.61
Days Sales Outstanding (DSO)	191.96	108.71	-43.37
Inventory Turnover	0.36	0.76	111.00
Debt/Capitalization	0.37	0.38	3.21
Quick Ratio	0.45	0.44	-1.94
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.83	1.81	-0.60
Cash	0.39	0.39	-1.04
Capex	< 0.005	< 0.005	56.88
Free Cash Flow	0.01	0.07	377.80
Revenue	0.44	0.79	82.35
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.77	0.77	0.90
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	22.91	-27.71	20.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating